Latest News about MNMD
Recent news which mentions MNMD
Psychedelic Stock Gainers And Losers From November 30, 2022
November 30, 2022
From Benzinga
From Benzinga
From Benzinga
7 F-Rated Stocks to Sell Before We Reach Christmas
November 28, 2022
From InvestorPlace
Psychedelic Stock Gainers And Losers From November 25, 2022
November 25, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From November 24, 2022
November 24, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From November 23, 2022
November 23, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From November 22, 2022
November 22, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From November 21, 2022
November 21, 2022
From Benzinga
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
November 18, 2022
From Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 17, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
November 16, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
From Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
November 15, 2022
From Benzinga
Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup
November 15, 2022
From Benzinga
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
November 10, 2022
From Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 09, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
November 08, 2022
From Benzinga
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
November 07, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
November 03, 2022
From Benzinga
Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S.
November 03, 2022
From Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
November 02, 2022
From Benzinga
From InvestorPlace
From MarketWatch
From Benzinga
Psychedelic Stock Gainers And Losers From October 26, 2022
October 26, 2022
From Benzinga
20-year-old investor who made $110 million on a meme stock is pushing for change at a psychedelics company
October 26, 2022
From MarketWatch
Psychedelic Stock Gainers And Losers From October 25, 2022
October 25, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
